Product Name: Naltrexone hydrochloride
Synonyms:17-(cyclopropylmethyl)-4,5-alpha-epoxy-3,14-dihydroxy-morphinan-6-onehydroch;n-cyclopropylmethyl-noroxymorphonehydrochloride
CAS:16676-29-2
MF:C20H24ClNO4
MW:377.86
EINECS:240-723-0
Product Categories:Intermediates & Fine Chemicals;Pharmaceuticals;Antagonists;Pharmacologicals;Enzyme Inhibitors by Type;Chiral Reagents
Melting point: 274-276ºC
Storage temp.: 2-8°C
Solubility: H2O: 50 mg/mL, clear, colorless
Water Solubility: Soluble in water at 50mg/ml.
Sensitive: Light Sensitive
Chemical Properties:White Crystalline Powder
Purity: 99%
Uses: Nonselective opioid receptor antagonist;congener of naloxone.
Uses:Analgesic;Opioid antagonist.
Uses: sulfonamide, carbonic anhydrase inhibitor, anti-glaucoma agent
Uses: Narcotic antagonist, In treatment of alcoholism .
Usage and dosage:
1. Preparation period: (1) No abuse of opioids within 7-10 days before starting medication. (2) Urinary morphine test should be negative. If positive, naltrexone hydrochloride treatment should be delayed until urine morphine is negative. (3) Naloxone hydrochloride provocation test before starting drug administration: After confirming that the urinary morphine test was negative, subcutaneous or intramuscular injection of 0.4 to 1.2 mg of naloxone hydrochloride was used to observe symptoms and signs for 1 hour. If there is no withdrawal symptoms, the test is negative. If positive, naltrexone hydrochloride treatment should be delayed until the challenge test is negative. 2. Induction period: The dose of naltrexone hydrochloride should be carefully and gradually increased at the beginning of treatment. The induction period is usually 3 to 5 days. The purpose of this period is to enable the drug users to gradually reach the appropriate dose of naltrexone hydrochloride. The induction period is carried out at the time of hospitalization. The induction method of drug use: Day 1: Oral naltrexone 2.5 mg~ 5mg. The first dose is generally the most obvious reaction. Severe reactions indicate that individuals are more dependent on opioids and should be suspended. The next day: oral 5mg ~ 15mg. The third day: oral 15mg ~ 30mg. The fourth day: oral 30mg ~ 40mg. The fifth day: 40 mg to 50 mg orally. 3. Maintenance period: (1) Dosage: 40 mg to 50 mg orally daily, once daily. (2) Course of treatment: In principle, as long as there is a possibility of relapse, naltrexone hydrochloride should be used for prevention. It is recommended to take naltrexone hydrochloride for at least six months.
 Related Products you may like
L(-)-Carnitine CAS:541-15-1
Synephrine CAS:94-07-5
LORCASERIN CAS : 856681-05-5
Orlistat CAS:96829-58-2
Cetilistat CAS : 282526-98-1
N-stearoylvanillylamide CAS : 58493-50-8
1,3-DiMethylpentanaMine Hydrochloride DMAA CAS: 13803-74-2
DMHA 1,5-DiMethylhexylaMine CAS: 543-82-8
DIMETHYL BENZYLAMINE DMBA / DMBZA CAS: 57-97-6
1,3-dimethyl-butylamine citrate / AMP Citrate
2-Dimethylaminoethanol (+)-bitartrate salt / DMAE bitartrate CAS: 5988-51-2
REVERSE T3 CAS:5817-39-0
3,5-Diiodo-L-thyronine / T2 CAS:1041-01-6
Sodium levothyroxine CAS: 25416-65-3
Levothyroxine sodium CAS: 55-03-8
Competitive Advantages :
1. 12 hour deliver after payment .
2. 20% lower price that the market price .
3. best free resend policy .
4. professional warehouse and reliable express agent with disguise package .
5. over 98% passing rate .
6. top quality is our life .
7. 24h after-sales service.
Anti-Glaucoma Agent API Powder CAS 16676-29-2 Naltrexone Hydrochloride
Product Name: Naltrexone hydrochloride
Synonyms:17-(cyclopropylmethyl)-4,5-alpha-epoxy-3,14-dihydroxy-morphinan-6-onehydroch;n-cyclopropylmethyl-noroxymorphonehydrochloride
CAS:16676-29-2
MF:C20H24ClNO4
MW:377.86
EINECS:240-723-0
Product Categories:Intermediates & Fine Chemicals;Pharmaceuticals;Antagonists;Pharmacologicals;Enzyme Inhibitors by Type;Chiral Reagents
Melting point: 274-276ºC
Storage temp.: 2-8°C
Solubility: H2O: 50 mg/mL, clear, colorless
Water Solubility: Soluble in water at 50mg/ml.
Sensitive: Light Sensitive
Chemical Properties:White Crystalline Powder
Purity: 99%
Uses: Nonselective opioid receptor antagonist;congener of naloxone.
Uses:Analgesic;Opioid antagonist.
Uses: sulfonamide, carbonic anhydrase inhibitor, anti-glaucoma agent
Uses: Narcotic antagonist, In treatment of alcoholism .
Usage and dosage:
1. Preparation period: (1) No abuse of opioids within 7-10 days before starting medication. (2) Urinary morphine test should be negative. If positive, naltrexone hydrochloride treatment should be delayed until urine morphine is negative. (3) Naloxone hydrochloride provocation test before starting drug administration: After confirming that the urinary morphine test was negative, subcutaneous or intramuscular injection of 0.4 to 1.2 mg of naloxone hydrochloride was used to observe symptoms and signs for 1 hour. If there is no withdrawal symptoms, the test is negative. If positive, naltrexone hydrochloride treatment should be delayed until the challenge test is negative. 2. Induction period: The dose of naltrexone hydrochloride should be carefully and gradually increased at the beginning of treatment. The induction period is usually 3 to 5 days. The purpose of this period is to enable the drug users to gradually reach the appropriate dose of naltrexone hydrochloride. The induction period is carried out at the time of hospitalization. The induction method of drug use: Day 1: Oral naltrexone 2.5 mg~ 5mg. The first dose is generally the most obvious reaction. Severe reactions indicate that individuals are more dependent on opioids and should be suspended. The next day: oral 5mg ~ 15mg. The third day: oral 15mg ~ 30mg. The fourth day: oral 30mg ~ 40mg. The fifth day: 40 mg to 50 mg orally. 3. Maintenance period: (1) Dosage: 40 mg to 50 mg orally daily, once daily. (2) Course of treatment: In principle, as long as there is a possibility of relapse, naltrexone hydrochloride should be used for prevention. It is recommended to take naltrexone hydrochloride for at least six months.
 Related Products you may like
L(-)-Carnitine CAS:541-15-1
Synephrine CAS:94-07-5
LORCASERIN CAS : 856681-05-5
Orlistat CAS:96829-58-2
Cetilistat CAS : 282526-98-1
N-stearoylvanillylamide CAS : 58493-50-8
1,3-DiMethylpentanaMine Hydrochloride DMAA CAS: 13803-74-2
DMHA 1,5-DiMethylhexylaMine CAS: 543-82-8
DIMETHYL BENZYLAMINE DMBA / DMBZA CAS: 57-97-6
1,3-dimethyl-butylamine citrate / AMP Citrate
2-Dimethylaminoethanol (+)-bitartrate salt / DMAE bitartrate CAS: 5988-51-2
REVERSE T3 CAS:5817-39-0
3,5-Diiodo-L-thyronine / T2 CAS:1041-01-6
Sodium levothyroxine CAS: 25416-65-3
Levothyroxine sodium CAS: 55-03-8
Competitive Advantages :
1. 12 hour deliver after payment .
2. 20% lower price that the market price .
3. best free resend policy .
4. professional warehouse and reliable express agent with disguise package .
5. over 98% passing rate .
6. top quality is our life .
7. 24h after-sales service.
Anti-Glaucoma Agent API Powder CAS 16676-29-2 Naltrexone Hydrochloride
Model NO.: 16676-29-2
Name: Naltrexone Hydrochloride
CAS: 16676-29-2
Appearance: White Crystalline Powder
Assay: 99%
Usage: Anti-Glaucoma Agent .
Trademark: WHSO
Transport Package: as You Requiry
Specification: 99%
Origin: China
HS Code: 3004390090
Model NO.: 16676-29-2
Name: Naltrexone Hydrochloride
CAS: 16676-29-2
Appearance: White Crystalline Powder
Assay: 99%
Usage: Anti-Glaucoma Agent .
Trademark: WHSO
Transport Package: as You Requiry
Specification: 99%
Origin: China
HS Code: 3004390090
Anti-Glaucoma Agent API Powder CAS 16676-29-2 Naltrexone Hydrochloride